Press Releases
 
Immunotherapy Drugs Market Current Trends and Future Aspect Analysis 2016 - 2024

, 25 April 2019 -- Traditionally, the basis of cancer treatment is comprised of radiation therapy, surgery, and chemotherapy. Recently, many positive treatment options have emerged in the field of immuno-oncology. These next generation cancer treatment options point to the opportunity of new improved techniques of anticancer therapy. Immunotherapy is termed as a biological therapy in which the primary aim is to improve the human immunity system to fight against diseases such as cancer and infectious diseases. Immunotherapy treatment increases the overall immunity of the body and confines the growth of cancer cells. The treatment allows immune cells to kill cancer cells from the body.

Read Report Overview:
https://www.transparencymarketresearch.com/immunotherapy-drugs-market.html

The global immunotherapy drugs market is driven by the rising incidences of cancer. The major factor for most cancers is the rise in geriatric population, as cancer rates increase with age. According to a report from WHO in 2015, approximately 50% of people treated with cancer in the U.K. are over the age of 60. Obesity, change in lifestyle, smoking, and eating habits are other important factors which are increasing the number of cancer patients. People are favoring toward cancer treatments with lesser side effects. This factor is likely to propel the growth of the global immunotherapy drugs market in the next few years, as immunotherapy drugs are found to have lesser side effects as compared to other treatments. Rise in opportunities in developing markets and immunotherapy as a substitute to chemotherapy for first line treatment are drivers which are expected to propel the growth of the market. In addition, quicker drug approval process and high prevalence rate of lifestyle diseases are projected to drive the market growth during the forecast period. However, high cost of immunotherapy devices, overall costly treatments, and lack of awareness about immunotherapy drugs and techniques are estimated to restrain the growth of the global immunotherapy drugs market in the near future.

The global immunotherapy drugs market is classified on the basis of type of drugs, application, end-user, and region. On the basis of type of drugs, the market is segmented into checkpoint inhibitors, ##### vaccines, interleukins, monoclonal antibodies, interferons, alpha and beta, and others. The ##### vaccines segment is subsegmented into therapeutic vaccines and preventive vaccines. The development of novel drugs and the entry of new molecules such as elotuzumab, obinutuzumab, zanolimumab, and onartuzumab into the market are projected to support the growth of this segment. On the basis of application, the market is classified as autoimmune and inflammatory diseases, cancer, infectious diseases, and others. The cancer segment is anticipated to hold a large part of the market share during the forecast period.

Geographically, the global immunotherapy drugs market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the market during the forecast period due to favorable government initiatives, healthy R&D investment, personalized medicine, development of next generation sequencing, and availability of technologically advanced health care research framework. According to a report by WHO in 2016, it is anticipated that 1.75 million new cancer patients are likely to be detected in the U.S. only. Asia Pacific is estimated to register a high growth rate of the immunotherapy drugs market in the next few years due to development of health care infrastructure, high disposable income, rise in health and hygiene related awareness, large untapped market base, and economic development.

Request Brochure of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=23771

Key players operating in the global immunotherapy drugs market include GE Healthcare; Thermo Fisher Scientific Inc.; Cepheid; F. Hoffmann-La Roche Ltd; OPKO Health, Inc.; Myriad Genetics, Inc.; Agilent Technologies; Koninklijke Philips N.V; Qiagen; Illumina, Inc.; Novartis AG; Abbott; PerkinElmer, Inc.; Genomic Health, Inc.; and Sysmex Corporation.

About us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
Website: https://www.transparencymarketresearch.com/



# # #


Submitted by hawer on Thursday, 25 April 2019 at 3:23 AM
Category: Health Care & Medical
 
Related News

Human Identity Testing Market to Grow at a Swift Pace by 2026
Wednesday, 22 May 2019

Human Identity Testing Market to Grow at a Swift Pace by 2026
Wednesday, 22 May 2019

Angiographic Catheter Market Set for Exquisite Growth with Globally Leading Players
Wednesday, 22 May 2019

Pouchitis Treatment Market to Witness Huge Growth in 2025
Wednesday, 22 May 2019

Radiosurgery Robotic Systems Market New Growth Opportunities by Leading Manufacturers
Wednesday, 22 May 2019

Related Events

TIDES: Oligonucleotide and Peptide Therapeutics | San Diego, CA
Monday, 20 May 2019

2019 EU Pharmaceutical Law Forum, Brussels
Tuesday, 21 May 2019

5th Precision CRISPR Genome Editing Congress
Tuesday, 21 May 2019

Dermatology Drug Development Summit Europe
Tuesday, 21 May 2019

NDD Europe 2019
Tuesday, 21 May 2019

Latest News

Pro-American Business Leader Daryl Guberman Stands With President Trump & ABAC Against Socialist ANS
Wednesday, 22 May 2019

The Benefits of Dance Classes
Wednesday, 22 May 2019

China Baby Tricycle Manufacturer Announces Availability Of Children Tricycle At Affordable Costs
Wednesday, 22 May 2019

Human Identity Testing Market to Grow at a Swift Pace by 2026
Wednesday, 22 May 2019

Human Identity Testing Market to Grow at a Swift Pace by 2026
Wednesday, 22 May 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Wednesday, 22 May 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • European Data Protection Days 2019 - The Berlin Conference
  • TIDES: Oligonucleotide and Peptide Therapeutics | San Diego, CA
  • LEAP HR: Oil and Gas Conference, Houston 2019
  • Argus Rio Crude Conference
  • VRX: Immersive Enterprise - Virtual And Augmented Reality Business ConfEx

  • Latest Jobs
    Sorry, there are currently no entries posted here.